Top section
Top section
Sale comes after the expiry last month of a pre-emptive acquisition rights agreement between the main family holding companies
Placing and open offer follows recent acquisition of US annuity provider
Long-time owners sell 0.5% stake after strong results
More articles
More articles
More articles
-
Ayala Land Real Estate Investment Trust is set to raise Ps12.3bn ($249.9m) from the Philippines' first Reit listing. -
Indian private sector lender Axis Bank has lined up four European banks for an equity sale that could raise up to Rp150bn ($2bn), according to a source close to the deal.
-
Sino Biopharmaceutical’s chief executive Tse Ping has sold a portion of his stake in the company for the second time this year, pocketing HK$3.15bn ($406.4m) but causing the stock price to tumble in the secondary market.
-
The European Commission is looking to change its rules on research unbundling and other aspects of MiFID II to ease the post-coronavirus recovery in the EU. It is also set to present tweaks to rules on securitization and prospectuses.
-
BioNTech, the German biopharmaceuticals company, is selling 5.5m American Depositary Receipts (ADRs) on the Nasdaq through a share sale and a rights issue. The company, which is working with Pfizer to develop a vaccine for Covid-19, is the latest issuer to hit the market in a wave of biotech ECM issuance — but buyers are being warned against being too eager, reports Sam Kerr.
-
Invesco changes fixed interest line-up — BofA makes Slowey equities head — NordLB hires two for DCM
Sub-sections
shared comment list
